Bioventus Inc.BVSNASDAQ
Loading
Revenue PerformanceStrong
Percentile Rank92
3Y CAGR+3.5%
5Y CAGR+12.1%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+3.5%/yr
vs +12.5%/yr prior
5Y CAGR
+12.1%/yr
Recent deceleration
Acceleration
-9.0pp
Decelerating
Percentile
P92
Near historical high
vs 5Y Ago
1.8x
Solid growth
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$568.09M-0.9%
2024$573.28M+11.9%
2023$512.35M+0.0%
2022$512.12M+18.8%
2021$430.90M+34.2%
2020$321.16M-5.6%
2019$340.14M+6.6%
2018$319.18M+9.3%
2017$292.06M+6.4%
2016$274.50M-